CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 98 filers reported holding CULLINAN ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,930,874 | -15.9% | 544,848 | 0.0% | 0.10% | -0.9% |
| Q2 2023 | $5,862,564 | -5.3% | 544,848 | -10.0% | 0.11% | -13.1% |
| Q1 2023 | $6,193,109 | -7.9% | 605,387 | -5.0% | 0.12% | -5.4% |
| Q4 2022 | $6,723,378 | -17.7% | 637,287 | 0.0% | 0.13% | -15.1% |
| Q3 2022 | $8,170,000 | -5.0% | 637,287 | -5.0% | 0.15% | -2.6% |
| Q2 2022 | $8,599,000 | +22.4% | 670,787 | 0.0% | 0.16% | +36.8% |
| Q1 2022 | $7,023,000 | -43.5% | 670,787 | -16.7% | 0.11% | -28.8% |
| Q4 2021 | $12,422,000 | -52.0% | 805,041 | -29.8% | 0.16% | -43.7% |
| Q3 2021 | $25,868,000 | -12.4% | 1,146,145 | 0.0% | 0.28% | -5.0% |
| Q2 2021 | $29,513,000 | -38.2% | 1,146,145 | 0.0% | 0.30% | -33.1% |
| Q1 2021 | $47,760,000 | – | 1,146,145 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $98,051,000 | 27.24% |
| CHI Advisors LLC | 3,047,609 | $39,070,000 | 14.92% |
| Nextech Invest Ltd. | 1,221,145 | $15,655,000 | 5.28% |
| BVF INC/IL | 7,509,059 | $96,266,000 | 4.65% |
| TANG CAPITAL MANAGEMENT LLC | 609,231 | $7,810,000 | 1.18% |
| Boxer Capital, LLC | 1,074,082 | $13,770,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 213,090 | $2,732,000 | 0.84% |
| Atom Investors LP | 96,880 | $1,242,000 | 0.54% |
| EcoR1 Capital, LLC | 1,169,889 | $14,998,000 | 0.52% |
| Birchview Capital, LP | 45,114 | $578,000 | 0.42% |